Ingrid Judith Garberis (Ingrid Garberis)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

End Stage Renal Disease

Prognostic Factors

Decision Making

Genome Wide Analysis

Top Venues

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Elie Rassy, Ingrid Judith Garberis, Alicia Tran-Dien, Bastien Job, Veronique Chung-Scott, Ibrahim Bouakka, Josiane Bassil, Rachel Ferkh, Magali Lacroix-Triki, Fabrizio Zanconati, Fabiola Giudici, Daniele Generali, Etienne Rouleau, Ludovic Lacroix, Fabrice Andre, Barbara Pistilli
Comparative genomic profiling of second breast cancers following first ipislateral hormone receptor-positive breast cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fernanda Mosele, Elise Deluche, Amelie Lusque, Loïc Le Bescond, Thomas Filleron, Yoann Pradat, Agnes Ducoulombier, Barbara Pistilli, Thomas Bachelot, Frederic Viret, Christelle Levy, Nicolas Signolle, Alexia Alfaro, Diep T N Tran, Ingrid Judith Garberis, Hugues Talbot, Stergios Christodoulidis, Maria Vakalopoulou, Nathalie M Droin, Aurelie Stourm, Maki Kobayashi, Tomoya Kakegawa, Ludovic Lacroix, Patrick Saulnier, Bastien Job, Marc Deloger, Marta Jimenez, Thierry Petit, Vianney Baris, Pierre Laplante, Patricia L Kannouche, Virginie Marty, Magali Lacroix-Triki, Véronique Diéras, Fabrice Andre
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial. Nature medicine (2023)